SCHEMBL7368811

SCHEMBL7368811

CC(C)CCNC(=O)CCCCCCC(=O)C(F)(F)F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.49
PKM P14618 1/20 0.49
FAAH O00519 11/20 0.49
CES1 P23141 7/20 0.49
CES2 O00748 2/20 0.49
MEN1 O00255 1/20 0.49
CYP1A2 P05177 1/20 0.49
KMT2A Q03164 1/20 0.49
HSD17B10 Q99714 1/20 0.49
CNR1 P21554 1/20 0.47
HPGD P15428 1/20 0.47
NAMPT P43490 1/20 0.46
HDAC6 Q9UBN7 2/20 0.45
HDAC3 O15379 1/20 0.44
NCOR1 O75376 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28340107 0.81 LMNA (0.58) LMNAPKMFAAHMEN1CYP1A2
SCHEMBL5866922 0.80 CNR1 (0.68) LMNAPKMFAAHMEN1KMT2A
SCHEMBL1456478 0.80 CNR1 (0.68) LMNAPKMFAAHMEN1KMT2A
SCHEMBL1456865 0.80 CNR1 (0.68) LMNAPKMFAAHMEN1KMT2A
SCHEMBL1695972 0.80 CNR1 (0.68) LMNAPKMFAAHMEN1KMT2A
SCHEMBL24490138 0.79 LMNA (0.50) LMNAPKMFAAHCNR1HPGD
SCHEMBL13328249 0.79 LMNA (0.60) LMNAPKMFAAHCNR1HPGD
SCHEMBL7552558 0.78 LMNA (0.53) LMNAPKMFAAHCNR1HPGD
SCHEMBL10443552 0.78 LMNA (0.55) LMNAPKMFAAHCNR1HPGD
SCHEMBL24383336 0.78 LMNA (0.55) LMNAPKMFAAHCNR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020103192-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-08-01 US claimed
US-20020177594-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-11-28 US disclosed
US-20020103192-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-08-01 US disclosed
WO-2002046129-A2 INHIBITORS OF HISTONE DEACETYLASE ABBOTT LABORATORIES (US) 2002-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020103192-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC4 LMNA 1705/4885PKM 147/4885FAAH 1179/4885
US-20020177594-A1 Inhibitors of histone deacetylase HDAC1, HDAC11, HDAC3 LMNA 1033/4885PKM 1131/4885FAAH 2579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.